Below are some examples of innovations developed at MidCentral:
For patients with chronic lung conditions, like cystic fibrosis, there are a number of different treatments that are prescribed by physios. One of them is the use of a Positive Expiratory Pressure (PEP) device. However, commercially available devices are prohibitively expensive, so physios often end up improvising a PEP device using a bottle of water and a straw.
Mike Perry, Respiratory Physio at MidCentral Health, decided to reinvent the PEP device, making it cost effective, safe and easy to use, so it could be available to a wider group of patients.
Mike completed his final design and reached agreement with a NZ company in November 2016, to supply his PEP device to the market. Look out for the new device on hospital shelves in DHB's around the country soon.
Babble - Baby Talk from MidCentral DHB
For parents of babies that are admitted to the NeoNatal Unit (NNU), it can be a very stressful time. Often a small amount of the information provided to parents in this early stage of becoming a parent is actually retained.
Dr Nathalie de Vries, Paediatrician at MidCentral Health, decided to develop a mobile app for parents that provides the key information about what to expect during their babies stay in the NNU. Parents can read and re-read information in the app in their own time. The app also provides a place to record key milestones, such as when a babies feeding tube is removed, which parents can share with their friends and whanau.
The app was released in May 2016 and is free for download from the App Store and Google Play Store. If you want to learn more about Babble, get in touch with the team at firstname.lastname@example.org.
RenalQ was developed from the work of the Renal Collaborative Clinical Pathway team. It is a software application created by Dr Greig Russell, with the help of Massey University and Medlab Central.
RenalQ provides decision support to GP's and other providers, who manage patients with renal disease. It was developed to address the practical challenges of interpreting eGFR test results, for assessing renal impairment, including:
The shear volume of test results received by providers each day.
That a “normal” result is situational, especially in renal impairment with an ageing population.
That providers often have only a single test result to consider.
The impact of the multi-disciplinary team – other members of the team may order tests that still need to be individually assessed.
RenalQ comments have been attached to lab results issued to over 100 providers in the MidCentral region since March 2015, with good feedback.